Boston Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-855	Closed	-$268K	–	631
2019 Q2	$268K	Sell	855 -10,688	-93%	-$3.56M	0.01%	584
2019 Q1	$4.74M	Sell	11,543 -5,165	-31%	-$2.13M	0.24%	114
2018 Q4	$6.24M	Buy	16,708 +8,710	+109%	+$3.19M	0.36%	67
2018 Q3	$3.23M	Buy	7,998 +7,267	+994%	+$2.77M	0.14%	230
2018 Q2	$252K	Sell	731 -5,985	-89%	-$1.87M	0.01%	603
2018 Q1	$2.31M	Buy	6,716 +1,810	+37%	+$630K	0.06%	263
2017 Q4	$1.84M	Sell	4,906 -360	-7%	-$146K	0.04%	288
2017 Q3	$2.35M	Sell	5,266 -430	-8%	-$205K	0.05%	277
2017 Q2	$2.8M	Buy	5,696 +465	+9%	+$203K	0.06%	274
2017 Q1	$2.03M	Sell	5,231 -1,921	-27%	-$712K	0.05%	284
2016 Q4	$2.63M	Sell	7,152 -325	-4%	-$124K	0.06%	281
2016 Q3	$3.01M	Buy	7,477 +80	+1%	+$32.1K	0.07%	251
2016 Q2	$2.58M	Buy	7,397 +1,095	+17%	+$422K	0.06%	258
2016 Q1	$2.27M	Buy	6,302 +303	+5%	+$125K	0.06%	255
2015 Q4	$3.26M	Buy	5,999 +518	+9%	+$281K	0.08%	236
2015 Q3	$2.55M	Sell	5,481 -947	-15%	-$509K	0.1%	239
2015 Q2	$3.28M	Sell	6,428 -78	-1%	-$38.1K	0.14%	172
2015 Q1	$2.94M	Buy	6,506 +3,585	+123%	+$1.52M	0.12%	191
2014 Q4	$1.2M	Buy	2,921 +125	+4%	+$49.2K	0.05%	246
2014 Q3	$1.01M	Buy	2,796 +5	+0.2%	+$1.68K	0.04%	273
2014 Q2	$788K	Sell	2,791 -74	-3%	-$21.9K	0.03%	304
2014 Q1	$860K	Buy	2,865 +195	+7%	+$60.1K	0.04%	284
2013 Q4	$735K	Sell	2,670 -7,995	-75%	-$2.3M	0.04%	302
2013 Q3	$3.34M	Buy	10,665 +85	+0.8%	+$22.4K	0.18%	134
2013 Q2	$2.38M	Buy	+10,580	New	+$2.46M	0.11%	155